globenewswire.comOCT 61 min read$SWIM

Latham Group, Inc. Announces Third Quarter 2026 Earnings Release and Conference Call Date

Latham Group, Inc. (SWIM) will release Q3 2026 earnings on Nov. 3, 2026, after market close. A conference call is scheduled for 4:30 PM ET. The company is the largest designer and manufacturer of in-ground residential pools in North America, Australia, and New Zealand, with 1,900 employees across 35 locations.

Original reporting

globenewswire.com

Published Oct 6, 2026, 8:05 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Oct 6, 2026, 8:08 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

AlphAI market briefEarnings

Primary signal

$SWIM

Neutral

high confidence

Mentioned

$SWIM

Relevance

4/10

AlphAI data visualization · based on globenewswire.com

Decision brief

The 30-second read

$SWIMNeutralLow

Why it matters

The press release serves as a formal notice of the upcoming earnings call, offering no new financial data.

Market read

The article is a routine earnings release announcement with minimal immediate trading relevance.

What to watch

Potential hidden guidance or market expectations may already be priced in, reducing the impact of the release date announcement.

Relevance 4/10Novelty 3/10Timing: pre‑market on Nov 3, 2026

Background

Latham Group is the largest designer and manufacturer of in‑ground residential swimming pools in North America, Australia, and New Zealand.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$SWIMNeutralHigh confidence

Context

Latham Group announced the date (Nov 3, 2026) for its Q3 2026 earnings release and conference call.

Expected impact

likely neutral as the market already expects an earnings release; no immediate price move expected.

Evidence & confidence

No new guidance or numbers were disclosed, only the release date, which typically has limited short‑term impact.

Market effects

Sector

None; the announcement does not affect the broader pool construction sector.

Regional

Limited to U.S. and Australian investors tracking Latham Group.

Global

Low; only relevant to shareholders and analysts of Latham Group.

Counterpoint

What could challenge this read

Investors could view the lack of substantive news as a sign to stay out until actual earnings are released.

Key entities

company
Latham Group, Inc.
Public pool manufacturer (NASDAQ: SWIM).

Read at source ← All news

SEP 1

HighAI 9/10

Latham Leads Epiris' £1B Buy Of Gamma Communications

Epiris LLP will acquire Gamma Communications PLC for £1.015 billion ($1.374 billion), taking the U.K. telecommunications company private, according to the firms. The deal was announced Tuesday.

law360.com1 min

AUG 22

Med

Latham Group Refinances Capital Structure with New Credit Facilities

Latham Group (SWIM) refinanced its capital structure with new credit facilities totaling $375 million. The facilities include a $75 million revolving credit line and a $300 million term loan, both secured by company assets. Proceeds were used to repay existing debt. The facilities mature in 2031 and 2033, respectively, and include leverage-based interest margins and covenants.

theglobeandmail.com1 min

AUG 21

Med

Latham Group Secures $375 Million Credit Facilities Led by Jefferies Finance; Replaces 2022 Loan

Latham Group (SWIM) secured $375 million in new credit facilities, including a $75 million revolving credit line and a $300 million term loan, led by Jefferies Finance. The facilities will refinance and extend the company's maturities, replacing a 2022 Barclays-led agreement. The revolver matures in 2031, and the term loan in 2033.

tradingview.com1 min

AUG 18

$FULCMedAI 8/10

Latham Advises Frazier Life Sciences on Private Placement Financing in Connection With Fulcrum Therapeutics and Slate Medicines Merger

Fulcrum Therapeutics (Nasdaq: FULC) and Slate Medicines announced a definitive all-stock merger. The combined company will operate as Slate Medicines, Inc. and is expected to trade on Nasdaq as SLTE. Slate secured commitments for an oversubscribed concurrent private placement of $245 million led by Frazier Life Sciences, with other healthcare investors participating.

lw.com2 min

AUG 12

$SWIMMedAI 8/10

Latham Group (SWIM) Q2 2026 Earnings Call Transcript

Latham Group, Inc. (SWIM) reported Q2 2026 net sales of $197.5 million, up 14.4% year over year, driven by 10.3% organic growth and the Freedom Pools acquisition. Adjusted EBITDA rose to $44.6 million. Net income fell to $12.8 million due to a $5.0 million FX impact. Full-year guidance: net sales $600 million to $620 million, adjusted EBITDA $110 million to $120 million.

fool.com7 min

AUG 5

$LOGCMedAI 8/10

Latham Represents Blackstone Credit & Insurance in Financing for ContextLogic’s Acquisition of gChem for US$850 Million

ContextLogic Holdings (OTCQB: LOGC) said it will acquire gChem, the holding company of Gaylord Chemical and subsidiaries, from funds managed by EagleTree Capital and co-investors. The deal values gChem at an enterprise value of US$850 million. Financing will come from Blackstone Credit & Insurance, including a US$250 million term loan and US$25 million revolver, per the company.